KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Raw Materials (2020 - 2023)

Teladoc Health's Raw Materials history spans 4 years, with the latest figure at $26.4 million for Q1 2023.

  • On a quarterly basis, Raw Materials rose 5.59% to $26.4 million in Q1 2023 year-over-year; TTM through Mar 2023 was $26.4 million, a 5.59% increase, with the full-year FY2022 number at $30.1 million, up 5.56% from a year prior.
  • Raw Materials hit $26.4 million in Q1 2023 for Teladoc Health, down from $30.1 million in the prior quarter.
  • Over the last five years, Raw Materials for TDOC hit a ceiling of $30.1 million in Q4 2022 and a floor of $17.0 million in Q2 2022.
  • Historically, Raw Materials has averaged $23.8 million across 4 years, with a median of $23.9 million in 2021.
  • Biggest five-year swings in Raw Materials: surged 45.68% in 2021 and later decreased 25.39% in 2022.
  • Tracing TDOC's Raw Materials over 4 years: stood at $19.6 million in 2020, then skyrocketed by 45.68% to $28.5 million in 2021, then rose by 5.56% to $30.1 million in 2022, then fell by 12.36% to $26.4 million in 2023.
  • Business Quant data shows Raw Materials for TDOC at $26.4 million in Q1 2023, $30.1 million in Q4 2022, and $27.6 million in Q3 2022.